Cresset Asset Management, LLC Cooper Companies, Inc. Transaction History

Cresset Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$306.88 - $380.0 $387,589 - $479,940	1,263 Added 36.23%	4,749 $1.8 Million
Q3 2023 Nov 14, 2023	BUY	$315.92 - $397.36 $110,572 - $139,076	350 Added 11.16%	3,486 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$346.15 - $392.09 $1.09 Million - $1.23 Million	3,136 New	3,136 $1.2 Million
Q4 2021 Feb 10, 2022	SELL	$373.53 - $434.12 $189,379 - $220,098	-507 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$396.76 - $455.92 $201,157 - $231,151	507 New	507 $209,000
Q2 2019 Aug 12, 2019	SELL	$279.29 - $336.89 $72,336 - $87,254	-259 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$246.18 - $297.25 $43,327 - $52,316	176 Added 212.05%	259 $77,000
Q4 2018 May 21, 2019	BUY	$232.7 - $281.66 $19,314 - $23,377	83 New	83 $21,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.